|
1.
|
Murabito JM, Evans JC, Larson MG, Nieto K,
Levy D and Wilson PW: The anklebrachial index in the elderly and
risk of stroke, coronary disease, and death: the Framingham Study.
Arch Intern Med. 163:1939–1942. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Hiatt WR: Medical treatment of peripheral
arterial disease and claudication. N Engl J Med. 344:1608–1621.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Belch JJ, Topol EJ, Agnelli G, et al:
Critical issues in peripheral arterial disease detection and
management: a call to action. Arch Intern Med. 163:884–892. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ross R: Atherosclerosis - an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar
|
|
5.
|
Ridker PM, Stampfer MJ and Rifai N: Novel
risk factors for systemic atherosclerosis: a comparison of
C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and
standard cholesterol screening as predictorsof peripheral arterial
disease. JAMA. 285:2481–85. 2001. View Article : Google Scholar
|
|
6.
|
McDermott MM, Green D, Greenland P, et al:
Relation of levels of hemostatic factors and inflammatory markers
to the ankle brachial index. Am J Cardiol. 92:194–199. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kolodgie FD, Burke AP, Skorija KS, et al:
Lipoprotein-associated phospholipase A2 protein expression in the
natural progression of human coronary atherosclerosis. Arterioscler
Thromb Vasc Biol. 26:2523–2529. 2006. View Article : Google Scholar
|
|
8.
|
Mannheim D, Herrmann J, Versari D, et al:
Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in
symptomatic carotid atherosclerotic plaques. Stroke. 39:1448–1455.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Rader DJ: Inflammatory markers of coronary
risk. N Engl J Med. 343:1179–1182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Karasawa K, Harada A, Satoh N, Inoue K and
Setaka M: Plasma platelet activating factor-acetylhydrolase
(PAF-AH). Prog Lipid Res. 42:93–114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Tsimikas S, Tsironis LD and Tselepis AD:
New insights into the role of lipoprotein(a)-associated
lipoprotein-associated phospholipase A2 in atherosclerosis and
cardiovascular disease. Arterioscler Thromb Vasc Biol.
27:2094–2099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
McConnell JP and Hoefner DM:
Lipoprotein-associated phospholipase A2. Clin Lab Med. 26:679–697.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Sudhir K: Lipoprotein-associated
phospholipase A2, a novel inflammatory biomarker and independent
risk predictor for cardiovascular disease. J Clin Endocrinol Metab.
90:3100–3105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Quigley FG, Faris IB and Duncan HJ: A
comparison of Doppler ankle pressures and skin perfusion pressure
in subjects with and without diabetes. Clin Physiol. 11:21–25.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Lijmer JG, Hunink MG, van den Dungen JJ,
Loonstra J and Smit AJ: ROC analysis of noninvasive tests for
peripheral arterial disease. Ultrasound Med Biol. 22:391–398. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Carter SA: The role of pressure
measurements in vascular disease. Non-Invasive Diagnostic
Techniques in Vascular Disease. Bernstein EF: Mosby; Missouri: pp.
513–544. 1985
|
|
17.
|
Yao IST: Pressure measurement in the
extremity. Vascular Diagnosis. Bernstein EF: 4th edition. Mosby;
Missouri: pp. 169–175. 1993
|
|
18.
|
Fowkes FG: The measurement of
atherosclerotic peripheral arterial disease in epidemiological
surveys. Int J Epidemiol. 17:248–154. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Hirsch AT, Haskal ZJ, Hertzer NR, et al:
ACC/AHA 2005 Practice Guidelines for the management of patients
with peripheral arterial disease (lower extremity, renal,
mesenteric and abdominal aortic). Circulation. 113:e463–e654. 2006.
View Article : Google Scholar
|
|
20.
|
The Lp-PLA2 Studies Collaboration:
Lipoprotein-associated phospholipase A2 and risk of coronary
disease, stroke, and mortality: collaborative analysis of 32
prospective studies. Lancet. 375:1536–1544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gong HP, Du YM, Zhong LN, Dong ZQ, Wang X,
Mao YJ and Lu QH: Plasma lipoprotein-associated phospholipase A2 in
patients with metabolic syndrome and carotid atherosclerosis.
Lipids Health Dis. 10:132011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ballantyne CM, Hoogeveen RC, Bang H,
Coresh J, Folsom AR, Heiss G and Sharrett AR:
Lipoprotein-associated phospholipase A2, high-sensitivity
C-reactive protein, and risk for incident coronary heart disease in
middle-aged men and women in the Atherosclerosis Risk in
Communities (ARIC) Study. Circulation. 109:837–842. 2004.
View Article : Google Scholar
|
|
23.
|
Brilakis ES, McConnell JP, Lennon RJ,
Elesber AA, Meyer JG and Berger PB: Association of
lipoprotein-associated phospholipase A2 levels with coronary artery
disease risk factors, angiographic coronary artery disease and
major adverse events at follow-up. Eur Heart J. 26:137–144. 2005.
View Article : Google Scholar
|
|
24.
|
Stafforini DM, Tjoelker LW, McCormick SP,
et al: Molecular basis of the interaction between plasma
platelet-activating factor acetylhydrolase and low density
lipoprotein. J Biol Chem. 274:7018–7024. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Alberti KG, Zimmet P, Shaw J, et al: The
metabolic syndrome - a new worldwide definition. Lancet.
366:1059–1062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kume N and Gimbrone MA Jr:
Lysophosphatidylcholine transcriptionally induces growth factor
gene expression in cultured human endothelial cells. J Clin Invest.
93:907–911. 1994. View Article : Google Scholar
|
|
27.
|
Tselepis AD and John Chapman M:
Inflammation, bioactive lipids and atherosclerosis: potential roles
of a lipoprotein-associated phospholipase A2, platelet activating
factor-acetylhydrolase. Atheroscler Suppl. 3:57–68. 2002.
View Article : Google Scholar
|
|
28.
|
Páramo JA, Beloqui O, Roncal C, Benito A
and Orbe J: Validation of plasma fibrinogen as a marker of carotid
atherosclerosis in subjects free of clinical cardiovascular
disease. Haematologica. 89:1226–1231. 2004.PubMed/NCBI
|
|
29.
|
Nasir K, Guallar E, Navas-Acien A, Criqui
Mh and Lima JA: Relationship of monocyte count and peripheral
arterial disease: results from the National Health and Nutrition
Examination Survey 1999–2002. Arterioscler Thromb Vasc Biol.
25:1966–1971. 2005.
|
